 BPH is a disease that affects seven of ten men---which explains why it's now the focus of so many office-based procedures. To help physicians treat this rapidly growing population, we now offer the following solution:
RevoLix Surgical Laser
Allows urologists to deliver similar results of a transurethral resection of the prostate (TURP) with a low incidence of complications and a high degree of safety.
Produces immediate and long-lasting relief of symptoms, a low incidence and short duration of catheterization, quick recovery, and very high patient satisfaction.
Click here for a patient brochure.
Click here for a patient brochure. (Spanish version)
For more information about RevoLix, email Tracy Stolarski
|
